Consumer Health Cancer / Immunology
First Approval in Japan for the KEYTRUDA Plus LENVIMA Combination
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Eisai today announced that the Japanese Ministry of Health, Labour and Welfare (M...
December 29, 2021 | News
Regor Therapeutics announced authorization from the USFDA to proceed with Regor's Phase 1 clinical development plans for RGT-419B.
On December 23, Regor Therapeutics, a clinical-stage biotech company, announced authorization from the US Food and Drug Administration ...
December 28, 2021 | News
Everest Medicines to treat Triple-Negative Breast Cancer in South Korea
Everest Medicines Limited (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing tran...
December 15, 2021 | News
Clarity and Cardinal Health to address the growing needs in oncology
Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address the growin...
December 03, 2021 | News
World-first lung cancer screening facility increases chance of cure
The truck will be fitted with the latest technology, integrating imaging, breath and blood biomarker screening, as part of a $2 million Australian Can...
December 01, 2021 | Influencers
Africa to benefit from advanced radiation therapy for cancer patients
Elekta (EKTA-B.ST) announced today that its latest African order for Elekta Unity MR-Linac comes less than six months after the company introduced its ACCE...
November 26, 2021 | News
Terumo Blood and Cell Technologies and Immunicom Establish Agreement to Launch Breakthrough Cancer Immunotherapy Treatment
Terumo Blood and Cell Technologies, a medical technology company specializing in a portfolio of products, software, and services for blood component ...
November 17, 2021 | News
Carina Biotech and CellVec advances clinical trials, making strides for colorectal cancer treatment
Singapore-based viral vector CDMO supplies lentiviruses to Carina Biotech, advancing first in-human clinical trial for bowel cancer treatment ...
November 10, 2021 | News
Veracyte Announces Immunoscore Colon Cancer Test
Veracyte, Inc. today announced that its Immunoscore Colon Cancer test has been included in the Pan-Asian adapted ESMO1 Clinical Practice Guideli...
November 08, 2021 | News
Hummingbird Bioscience collaborates with Merck for a clinical trial on HMBD-002, our anti-VISTA antibody, in combination with KEYTRUDA®
Under this collaboration, Hummingbird will evaluate the safety, tolerability, and anti-tumor activity of its novel anti-VISTA antibody, HMBD-002, i...
October 26, 2021 | News
Rakuten,Karkinos Healthcare Announce Partnership to Expand Novel Cancer Care in India
Rakuten Medical is focused on developing and commercializing innovative cancer treatments for multiple indications based on its Illuminox™ platform. ...
October 25, 2021 | News
PharmAbcine Announces Patent Grant in Australia for Its Anti-VISTA Antibody
The Australian grant represents PMC-309's third global patent approval since it received grants from Russia in June 2021 and South...
October 20, 2021 | News
Fujitsu and Aichi Cancer Center Develop AI System to Offer Patients Personalized Cancer Treatment
News Facts: - Aichi Cancer Center and Fujitsu jointly developed new AI solution to support physicians in efficiently choosing medical treatment expected t...
October 19, 2021 | News
Hummingbird Bioscience to Present Pre-Clinical Data on Novel Biomarkers for HER3-driven Cancers
Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, today announce...
October 08, 2021 | News
Most Read
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
